Lenzing's Rights Issue Is Banked; Heiligenkreuz Still Holds the Pen

Lenzing has closed the financing chapter of its restructuring. The operating one remains wide open, and the market's attention is now split between a plant sale running to a year-end deadline and a share register that has been reshaped without disturbing who controls the company.

Shares in the Austrian fibre maker climbed 6.0% as investors weighed reports that the sale process for the Heiligenkreuz site is entering its decisive stretch. Roughly 30 parties have expressed interest, with the field due to be narrowed in mid-November. By the end of the year it should be clear whether a new owner keeps the plant running or it is shut down. About 285 people work at the site.

Shutdown Pushed Into 2027

Lenzing confirmed around two weeks ago that production at Heiligenkreuz would not stop until the first quarter of 2027, having previously targeted the end of 2026. A company spokesperson cited the transfer of production as the reason for the delay, according to ORF.

The plant question sits on a separate track from the capital measures and should be judged on its own terms. One concerns who holds voting rights; the other concerns how an operational change is carried out. Both matter to investors, but neither substitutes for the other.

A Register Redrawn, a Majority Untouched

The company's total voting rights stood at 73,374,542 at the end of the month, against share capital of EUR 76,204,702.90. Those figures describe the new capital base — they do not by themselves demonstrate business success.

What the completed rights offering does show is solid take-up. The subscription ratio reached 99.0%, with shares offered at EUR 8.65 apiece. Lenzing put the final gross proceeds at EUR 301.2 million, against an earlier planned figure of around EUR 300 million. That is a clear statement about demand for the stock on offer — and nothing more. A high subscription rate speaks to participation in the transaction, not to future earnings or a particular share price trajectory. The term "gross proceeds" also deserves care: it describes cash flowing in from the placement, not operating profit.

Ownership continuity is the other half of the picture. The syndicate of B&C Group and Suzano S.A. still holds around 52.25% of voting rights, Lenzing said in a Thursday statement. Suzano Holding S.A. acquired a direct stake of roughly 0.80% through the capital increase, while Goldman Sachs Group holds 5.86%, according to company disclosures.

Read only the cash inflow and you miss that continuity. Read only the majority structure and you underestimate how much the capital base has changed.

Analysts Trim Their Targets

Deutsche Bank Research cut its price target to EUR 12.70 from EUR 22.00 a little over a week ago, keeping its "Hold" rating. The next confirmed date on Lenzing's financial calendar is the third-quarter 2026 results release on 5 November, with a presentation scheduled from 15:00 to 16:00 CET.

The discipline the case demands is straightforward: a completed financing and a completed business are answers to different investor questions. Lenzing has described its capital structure and banked the proceeds. It has not yet answered what the operations will deliver.